Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Manoj Leethochawalit"'
Autor:
Pravan Suntharasamai, Michael Martin, Kachit Choopanya, Suphak Vanichseni, Udomsak Sangkum, Pairote Tararut, Wanna Leelawiwat, Rapeepan Anekvorapong, Philip A Mock, Thitima Cherdtrakulkiat, Manoj Leethochawalit, Sithisat Chiamwongpaet, Roman J Gvetadze, Janet M McNicholl, Lynn A Paxton, Somyot Kittimunkong, Marcel E Curlin
Publikováno v:
PLoS ONE, Vol 10, Iss 12, p e0145859 (2015)
Rapid easy-to-use HIV tests offer opportunities to increase HIV testing among populations at risk of infection. We used the OraQuick Rapid HIV-1/2 antibody test (OraQuick) in the Bangkok Tenofovir Study, an HIV pre-exposure prophylaxis trial among pe
Externí odkaz:
https://doaj.org/article/62b653961a924bb08e15a47cc0538fe6
Autor:
Michael Martin, Suphak Vanichseni, Pravan Suntharasamai, Udomsak Sangkum, Philip A Mock, Manoj Leethochawalit, Sithisat Chiamwongpaet, Roman J Gvetadze, Somyot Kittimunkong, Marcel E Curlin, Dararat Worrajittanon, Janet M McNicholl, Lynn A Paxton, Kachit Choopanya, Bangkok Tenofovir Study Group
Publikováno v:
PLoS ONE, Vol 9, Iss 3, p e92809 (2014)
INTRODUCTION: HIV spread rapidly among people who inject drugs in Bangkok in the late 1980s. In recent years, changes in drug use and HIV-associated risk behaviors have been reported. We examined data from the Bangkok Tenofovir Study, an HIV pre-expo
Externí odkaz:
https://doaj.org/article/9d78472fb51f4c979355654ee5070578
Autor:
Michael Martin, Suphak Vanichseni, Pravan Suntharasamai, Udomsak Sangkum, Rutt Chuachoowong, Philip A Mock, Manoj Leethochawalit, Sithisat Chiamwongpaet, Somyot Kittimunkong, Frits van Griensven, Janet M McNicholl, Lynn Paxton, Kachit Choopanya, Bangkok Tenofovir Study Group
Publikováno v:
PLoS ONE, Vol 6, Iss 9, p e25127 (2011)
The Bangkok Tenofovir Study was launched in 2005 to determine if pre-exposure prophylaxis with tenofovir will reduce the risk of HIV infection among injecting drug users (IDUs). We describe recruitment, screening, enrollment, and baseline characteris
Externí odkaz:
https://doaj.org/article/eda843ceb07c40b48a2007d1c00e6ad0
Autor:
Suphak Vanichseni, Manoj Leethochawalit, Philip A. Mock, Sithisat Chiamwongpaet, Somyot Kittimunkong, Jordan W. Tappero, Janet M. McNicholl, Kachit Choopanya, Frits van Griensven, Udomsak Sangkum, Punnee Pitisuttithum, Jaranit Kaewkungwal, Timothy D. Mastro, Michael Martin
Publikováno v:
EClinicalMedicine
Background Three consecutive prospective studies were conducted among people who inject drugs (PWID) from May 1995 through June 2012 in Bangkok, Thailand. We examined data from these studies to evaluate HIV incidence and explore trends in risk behavi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ae0273a0379e641df62a2dc56a4fb9c
https://pubmed.ncbi.nlm.nih.gov/31143881
https://pubmed.ncbi.nlm.nih.gov/31143881
Autor:
Manoj Leethochawalit, Kachit Choopanya, Pravan Suntharasamai, Somyot Kittimunkong, Marcel E. Curlin, Philip A. Mock, Suphak Vanichseni, Lynn A. Paxton, Janet M. McNicholl, Anchalee Warapronmongkholkul, Udomsak Sangkum, Roman Gvetadze, Michael Martin, Sithisat Chiamwongpaet, Supawadee Na-pompet
Publikováno v:
AIDS. 29:819-824
OBJECTIVE To describe participant adherence to daily oral tenofovir in an HIV preexposure prophylaxis (PrEP) trial, examine factors associated with adherence, and assess the impact of adherence on the risk of HIV infection. DESIGN The Bangkok Tenofov
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::932cbbf5da02ef99b79794aa367aea3c
https://doi.org/10.1097/qad.0000000000000613
https://doi.org/10.1097/qad.0000000000000613
Autor:
Michael Martin, Suphak Vanichseni, Wanna Leelawiwat, Rapeepan Anekvorapong, Boonyos Raengsakulrach, Thitima Cherdtrakulkiat, Udomsak Sangkum, PhilipA Mock, Manoj Leethochawalit, Sithisat Chiamwongpaet, JanetM McNicholl, Somyot Kittimunkong, MarcelE Curlin, Kachit Choopanya, null for the Bangkok Tenofovir Study Group
Publikováno v:
WHO South East Asia J Public Health
BACKGROUND: Approximately 1% of adults in Thailand are infected with hepatitis C virus (HCV). New direct-acting antiviral agents achieve sustained virologic responses in >95% of HCV-infected patients and are becoming available in countries around the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9fdfb94bf0ef3943fa697a00cb383e86
https://doi.org/10.4103/2224-3151.255350
https://doi.org/10.4103/2224-3151.255350
Autor:
Marcel E. Curlin, Philip A. Mock, Michael Martin, Kachit Choopanya, Manoj Leethochawalit, Timothy H. Holtz, Pravan Suntharasamai, Sithisat Chiamwongpaet, Dararat Worrajittanon, Janet M. McNicholl, Taraz Samandari, Suphak Vanichseni, Somyot Kittimunkong, Lynn A. Paxton, Udomsak Sangkum, Roman Gvetadze, Benjamaporn Chaipung
Publikováno v:
The lancet. HIV. 4(2)
Results of the randomised, double-blind, placebo-controlled Bangkok Tenofovir Study (BTS) showed that taking tenofovir daily as pre-exposure prophylaxis (PrEP) can reduce the risk of HIV infection by 49% in people who inject drugs. In an extension to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ffc1e590205480d331f024e08dd24660
https://pubmed.ncbi.nlm.nih.gov/27866872
https://pubmed.ncbi.nlm.nih.gov/27866872
Autor:
Michael Martin, Philip A. Mock, Suphak Vanichseni, Manoj Leethochawalit, Benjamaporn Chaipung, Kachit Choopanya, Pravan Suntharasamai, Sithisat Chiamwongpaet, Udomsak Sangkum, Roman Gvetadze, Somyot Kittimunkong, Lynn A. Paxton, Janet M. McNicholl, Marcel E. Curlin
Objectives. We examined the causes of hospitalization and death of people who inject drugs participating in the Bangkok Tenofovir Study, an HIV preexposure prophylaxis trial. Methods. The Bangkok Tenofovir Study was a randomized, double-blind, placeb
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2dbe58a2f1ea214ff054b3aa989d3c51
https://europepmc.org/articles/PMC4431084/
https://europepmc.org/articles/PMC4431084/
Autor:
Roman Gvetadze, Udomsak Sangkum, Kachit Choopanya, Wanna Leelawiwat, Pravan Suntharasamai, Rapeepan Anekvorapong, Marcel E. Curlin, Pairote Tararut, Sithisat Chiamwongpaet, Somyot Kittimunkong, Lynn A. Paxton, Suphak Vanichseni, Manoj Leethochawalit, Janet M. McNicholl, Thitima Cherdtrakulkiat, Michael Martin, Philip A. Mock
Publikováno v:
PLoS ONE, Vol 10, Iss 12, p e0145859 (2015)
PLoS ONE
PLoS ONE
Background Rapid easy-to-use HIV tests offer opportunities to increase HIV testing among populations at risk of infection. We used the OraQuick Rapid HIV-1/2 antibody test (OraQuick) in the Bangkok Tenofovir Study, an HIV pre-exposure prophylaxis tri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d754a9a1096425b71f1f2a5986502b7
http://europepmc.org/articles/PMC4696659?pdf=render
http://europepmc.org/articles/PMC4696659?pdf=render
Autor:
Kachit Choopanya, Pravan Suntharasamai, Suphak Vanichseni, Rapeepan Anekvorapong, Nartlada Chantharojwong, Thitima Cherdtrakulkiat, Janet M. McNicholl, Udomsak Sangkum, Wanna Leelawiwat, Roman Gvetadze, Michael Martin, Marcel E. Curlin, Philip A. Mock, Somyot Kittimunkong, Lynn A. Paxton, Manoj Leethochawalit, Sithisat Chiamwongpaet
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 59(5)
BACKGROUND Tenofovir disoproxil fumarate (tenofovir) has been associated with renal dysfunction in people infected with human immunodeficiency virus (HIV) receiving combination antiretroviral therapy. We reviewed data from an HIV preexposure prophyla
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8b8de0c47dec724413b31d687408a697
https://pubmed.ncbi.nlm.nih.gov/24829212
https://pubmed.ncbi.nlm.nih.gov/24829212